Pitts’ Bill to Speed Drug Reviews Approved by Energy and Commerce Committee

Jun 10, 2014 Issues: Health Care

The full Energy and Commerce Committee approved Congressman Joe Pitts’ (R-PA) bipartisan legislation to speed new therapies to patients today by a voice vote. H.R. 4299, introduced with Health Subcommittee Ranking Member Frank Pallone (D-NJ), would improve efficiency, transparency, and consistency of the Drug Enforcement Agency’s process for scheduling new drugs approved by the Food and Drug Administration.

“My bill, approved by the committee today, will allow new and innovative treatments to get to patients who desperately need them faster,” said Pitts. “The bill creates a sensible timeline for DEA review of drugs that have already been looked at by the FDA. It also establishes a timeline for the DEA to approve clinical trials for new drugs. This should help boost innovation.”

H.R. 4299 is the second of three bills that Pitts has introduced with Pallone in this Congress. The third bill, H.R. 4771, the Designer Anabolic Steroid Control Act, was introduced in May and could be considered by the Health Subcommittee and full Energy and Commerce Committee this summer. Overall, the Health Subcommittee has seen ten bills under its jurisdiction signed into law since the 113th Congress began in January 2013.

“As Chairman of the Health Subcommittee, I’m proud of the work we’ve done to bridge the partisan divide and get good public health bills signed into law,” said Pitts. “I’m going to continue looking for areas of agreement so that we can build trust to move forward together on the larger reforms we need to improve health care for everyone.”